BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 24862203)

  • 1. Lambert-Eaton syndrome antibodies target multiple subunits of voltage-gated Ca2+ channels.
    Hajela RK; Huntoon KM; Atchison WD
    Muscle Nerve; 2015 Feb; 51(2):176-84. PubMed ID: 24862203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Autoantibody against the presynaptic P/Q-type voltage-gated calcium channel in Lambert-Eaton myasthenic syndrome].
    Sakai W; Nakane S; Matsuo H
    Brain Nerve; 2013 Apr; 65(4):441-8. PubMed ID: 23568992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome].
    Iwasa K; Komai K; Yasukawa Y; Maruta T; Takamori M
    Nihon Rinsho; 1997 Dec; 55(12):3322-30. PubMed ID: 9436458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies.
    Titulaer MJ; Lang B; Verschuuren JJ
    Lancet Neurol; 2011 Dec; 10(12):1098-107. PubMed ID: 22094130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel.
    Pellkofer HL; Armbruster L; Krumbholz M; Titulaer MJ; Verschuuren JJ; Schumm F; Voltz R
    J Neuroimmunol; 2008 Nov; 204(1-2):136-9. PubMed ID: 18809213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome.
    Lang B; Pinto A; Giovannini F; Newsom-Davis J; Vincent A
    Ann N Y Acad Sci; 2003 Sep; 998():187-95. PubMed ID: 14592874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of calcium channel autoantibodies detected using a small-cell lung cancer line derived from a Lambert-Eaton myasthenic syndrome patient.
    Johnston I; Lang B; Leys K; Newsom-Davis J
    Neurology; 1994 Feb; 44(2):334-8. PubMed ID: 8309586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
    Motomura M; Lang B; Johnston I; Palace J; Vincent A; Newsom-Davis J
    J Neurol Sci; 1997 Mar; 147(1):35-42. PubMed ID: 9094058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to active zone protein ERC1 in Lambert-Eaton myasthenic syndrome.
    Huijbers MG; Lipka AF; Potman M; Hensbergen PJ; Titulaer MJ; Niks EH; van der Maarel SM; Klooster R; Verschuuren JJ
    Hum Immunol; 2013 Jul; 74(7):849-51. PubMed ID: 23583364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.
    Pinto A; Iwasa K; Newland C; Newsom-Davis J; Lang B
    Muscle Nerve; 2002 May; 25(5):715-724. PubMed ID: 11994966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes.
    Lennon VA; Kryzer TJ; Griesmann GE; O'Suilleabhain PE; Windebank AJ; Woppmann A; Miljanich GP; Lambert EH
    N Engl J Med; 1995 Jun; 332(22):1467-74. PubMed ID: 7739683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies.
    Flink MT; Atchison WD
    J Bioenerg Biomembr; 2003 Dec; 35(6):697-718. PubMed ID: 15000529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lambert-Eaton myasthenic syndrome: search for alternative autoimmune targets and possible compensatory mechanisms based on presynaptic calcium homeostasis.
    Takamori M
    J Neuroimmunol; 2008 Sep; 201-202():145-52. PubMed ID: 18653248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to calcium channel and synaptotagmin in Lambert-Eaton myasthenic syndrome.
    Takamori M; Komai K; Iwasa K
    Am J Med Sci; 2000 Apr; 319(4):204-8. PubMed ID: 10768604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer.
    Pelucchi A; Ciceri E; Clementi F; Marazzini L; Foresi A; Sher E
    Am Rev Respir Dis; 1993 May; 147(5):1229-32. PubMed ID: 8387255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome].
    Motomura M; Suenaga A; Matsuo H; Tsujihata M; Nagataki S
    Rinsho Shinkeigaku; 1994 Oct; 34(10):980-4. PubMed ID: 7834958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder.
    Vincent A; Lang B; Newsom-Davis J
    Trends Neurosci; 1989 Dec; 12(12):496-502. PubMed ID: 2480664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
    Kitanosono H; Shiraishi H; Motomura M
    Brain Nerve; 2018 Apr; 70(4):341-355. PubMed ID: 29632282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against the calcium channel beta-subunit in Lambert-Eaton myasthenic syndrome.
    Verschuuren JJ; Dalmau J; Tunkel R; Lang B; Graus F; Schramm L; Posner JB; Newsom-Davis J; Rosenfeld MR
    Neurology; 1998 Feb; 50(2):475-9. PubMed ID: 9484375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low specificity of voltage-gated calcium channel antibodies in Lambert-Eaton myasthenic syndrome: a call for caution.
    Di Lorenzo R; Mente K; Li J; Shayya L; Rae-Grant A; Li Y; Jammoul A
    J Neurol; 2018 Sep; 265(9):2114-2119. PubMed ID: 29987589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.